GlassScriptPhysician profile
Brittany Fowler
NPI 1275917866
$2,097.04
in general payments reported to CMS, 2019-2025
22 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $224 · 2023: $799 · 2024: $630 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $824.84 | 2021-2025 | |
| Myriad Women'S Health, INC. | $363.94 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $128.58 | 2022-2024 | |
| Exeltis, USA INC. | $117.10 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $99.91 | 2022-2025 | Veozah, Myrbetriq |
| Channel Medsystems, INC. | $77.69 | 2024 | |
| Sumitomo Pharma America, INC. | $56.81 | 2023-2024 | Myfembree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.35 | 2021-2023 | Xifaxan |
| Acella Pharmaceuticals, LLC | $47.43 | 2023-2025 | NP Thyroid 60 |
| Gynesonics, INC. | $45.70 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $37.56 | 2024-2025 | Paragard T 380a |
| Biohaven Pharmaceutical Holding Company LTD. | $35.42 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $34.50 | 2021 | |
| Lupin INC. | $29.54 | 2021 | |
| Ibsa Pharma INC. | $28.50 | 2023-2024 | Tirosint, Licart, Licart |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.99 | 2023 | Vyepti |
| Evofem Biosciences, INC. | $20.45 | 2021 | |
| Scynexis, INC. | $18.42 | 2022 | |
| Pfizer INC. | $18.28 | 2024 | |
| Hologic Sales and Service, LLC | $14.24 | 2022 | |
| Millicent US INC | $13.73 | 2025 | Femlyv |
| Minerva Surgical, INC | $13.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.